Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Servier

Oncology Today

Oncology Today—June 8, 2026

This week’s Oncology update highlights regulatory approvals, priority review…

Lucid Diligence Brief - BioPharma

Servier Edgewise Sevasemten Deal | Lucid Diligence Brief

Servier’s Edgewise acquisition puts sevasemten’s Becker muscular dystrophy data…

by Marione Briones

Onco_background

Oncology Today—May 11, 2026

This week’s Oncology update highlights regulatory progress, late-stage clinical…

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: kyron.bio x Servier strategic partnership

Lucid Diligence Brief: kyron.bio x Servier strategic partnership Professional…

by Timos Papagatsias

Onco_background

Oncology Weekly News - September 29th 2025

Oncology Update: Vorasidenib Approval, Plixorafenib Efficacy, OPDIVO…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Respiratory Today—June 26, 2026
Vaccines Today—June 26, 2026
Public Health Today—June 26, 2026
Cell and Gene Therapy Today—June 25, 2026
Rare Diseases Today—June 25, 2026

Tags

ABP-745 Alfasigma biologics manufacturing BRAIx Risk Score Canine Pruritus CVS Pharmacy AI Screening drug discovery partnerships EB613 ELEVATE-HFpEF ENHERTU Eupraxia Pharmaceuticals Exosomes Eyenuk EyeArt FluoGuide Fractional Flow Reserve frexalimab G2GBIO GE HealthCare Influenza Vaccine Intercept Pharmaceuticals K-cell technology label update MB097 Metabolic Surgery mNexspike molecular glue degrader Moleculin NT-proBNP Ocrelizumab Office On Women’s Health Ornithine Transcarbamylase Deficiency pouchitis Premature birth progressive MS Sanaregen Vision Therapeutics Spinal muscular atrophy type 1 Stablepharma Sumitomo Pharma T11 Pro AI Mattress transformers AI Ultra-processed foods VALANX Biotech verapamil SR XOSPATA Xtandi

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Respiratory Today—June 26, 2026
Vaccines Today—June 26, 2026
Public Health Today—June 26, 2026
Cell and Gene Therapy Today—June 25, 2026
Rare Diseases Today—June 25, 2026

TAGS

ABP-745 Alfasigma biologics manufacturing BRAIx Risk Score Canine Pruritus CVS Pharmacy AI Screening drug discovery partnerships EB613 ELEVATE-HFpEF ENHERTU Eupraxia Pharmaceuticals Exosomes Eyenuk EyeArt FluoGuide Fractional Flow Reserve frexalimab G2GBIO GE HealthCare Influenza Vaccine Intercept Pharmaceuticals K-cell technology label update MB097 Metabolic Surgery mNexspike molecular glue degrader Moleculin NT-proBNP Ocrelizumab Office On Women’s Health Ornithine Transcarbamylase Deficiency pouchitis Premature birth progressive MS Sanaregen Vision Therapeutics Spinal muscular atrophy type 1 Stablepharma Sumitomo Pharma T11 Pro AI Mattress transformers AI Ultra-processed foods VALANX Biotech verapamil SR XOSPATA Xtandi

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy